Work

PL02.08 Perioperative vs Neoadjuvant Nivolumab for Resectable NSCLC: Patient-Level Data Analysis of CheckMate 77T vs CheckMate 816

Year: 2024

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2024.09.014

Authors: P.M. Forde, S. Peters, J. Donington, S. Meadows-Shropshire, P. Tran, S. Lucherini, C. Coronado Erdmann, H. Sun, T. Cascone

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, Centre Hospitalier Universitaire Vaudois, University of Chicago, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (United Kingdom), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4403410401

Cites:

Cited by: 58

Related to: 10